The fact that we know injections of succinate accelerate experimental atherosclerosis [33], as well as our discovery of significantly lower levels of succinate in the plasma of hyperlipidemic Gpr91−/− mice implies that lesions could be reduced later on under similar experimental conditions. The gene discussed is SUCNR1; the disease is atherosclerosis.